Ali Saffaei

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 13

Top Venues

Iranian journal of pharmaceutical research : IJPR

Journal of cosmetic dermatology

Journal of medical virology

Clinical case reports

Shahid Beheshti University of Medical Sciences

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Shahid Beheshti University of Medical Sciences Sep 23 2017

Iran

Resident :: Clnical Pharmacy

Publications

Ali Saffaei, Jafar Amani, Jafar Salimian, Gholamhossein Alishiri, Hassan Abolghasemi
Comments on "Comparative Immunogenicity and Neutralization Potency of Four Approved COVID-19 Vaccines in BALB/c Mice". Iranian journal of immunology : IJI 21 (3) (2024)
Amin Rakhshan, Bardia Rahmati Kamel, Ali Saffaei, Maria Tavakoli Ardakani
Hepatotoxicity Induced by Azole Antifungal Agents: A Review Study. Iranian journal of pharmaceutical research : IJPR 22 (1) (2023)
Amin Rakhshan, Bardia Rahmati Kamel, Ali Saffaei, Maria Tavakoli Ardakani
Hepatotoxicity Induced by Azole Antifungal Agents: A Review Study. Iranian journal of pharmaceutical research : IJPR 22 (1) (2023)
Ilad Alavi Darazam, Kimia Forouhar, Omid Moradi, Ali Saffaei, Mahtabalsadat Mirjalili, Zahra Sahraei
Efficacy and Safety of Two Different Enoxaparin Doses for Thromboprophylaxis in Non-critically Ill Patients: A Randomized Controlled Trial. Iranian journal of pharmaceutical research : IJPR 21 (1) (2022)
Bahareh Abtahi-Naeini, Fereshteh Rastegarnasab, Ali Saffaei
Liquid vitamin E injection for cosmetic facial rejuvenation: A disaster report of lipogranuloma. Journal of cosmetic dermatology (2022)
Zahra Sahraei, Bahareh Abtahi-Naeini, Ali Saffaei
Sputnik-V vaccine-induced panniculitis as a local reactions. Clinical case reports 10 (6) (2022)
Ilad Alavi Darazam, Kimia Forouhar, Omid Moradi, Ali Saffaei, Mahtabalsadat Mirjalili, Zahra Sahraei
Efficacy and Safety of Two Different Enoxaparin Doses for Thromboprophylaxis in Non-critically Ill Patients: A Randomized Controlled Trial. Iranian journal of pharmaceutical research : IJPR 21 (1) (2022)
Jafar Salimian, Ali Ahmadi, Jafar Amani, Gholamreza Olad, Raheleh Halabian, Ali Saffaei, Masoud Arabfard, Mojtaba Nasiri, Shahram Nazarian, Hassan Abolghasemi, Gholamhossein Alishiri
Safety and immunogenicity of a recombinant receptor-binding domain-based protein subunit vaccine (Noora vaccine™) against COVID-19 in adults: A randomized, double-blind, placebo-controlled, Phase 1 trial. Journal of medical virology (2022)
Zargham Hossein Ahmadi, Alireza Jahangirifard, Behrooz Farzanegan, Payam Tabarsi, Zahra Abtahian, Atefeh Abedini, Mehrzad Sharifi, Amir Naser Jadbabaei, Yadollah Mafhumi, Ali Moslem, Marjan Sistani, Sahar Yousefian, Ali Saffaei, Farzaneh Dastan
Extracorporeal membrane oxygenation and COVID-19: The causes of failure. Journal of cardiac surgery 35 (10) (2020)
Bahareh Abtahi-Naeini, Ali Saffaei
COVID-19 and elective cosmetic procedures: Asymptomatic transmission in epidemic area and subsequent burdens. Journal of cosmetic dermatology 19 (8) (2020)
Minoosh Shabani Barzegar, Shervin Shokouhi, Omid Moradi, Ali Saffaei, Zahra Sahraei
Tocilizumab administration in patients with SARS-CoV-2 infection: Subcutaneous injection vs intravenous infusion. Journal of medical virology 93 (1) (2020)
Nikoo Mozafari, Ali Saffaei, Mohammad Alizadeh, Minoosh Shabani Barzegar
Cutaneous necrotic lesion: A wonderful delay adverse effect of interferon beta-1b injection for multiple sclerosis treatment. Journal of cosmetic dermatology 19 (4) (2019)
Bahareh Abtahi-Naeini, Gita Faghihi, Zabihollah Shahmoradi, Ali Saffaei
Filler migration and extensive lesions after lip augmentation: Adverse effects of polydimethylsiloxane filler. Journal of cosmetic dermatology 17 (6) (2018)

Ali Saffaei.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Ali Saffaei